Romidepsin is effective in subcutaneous panniculitis-like T-cell lymphoma

Journal of Clinical Oncology

Volumn 30, Issue 24, 2012, Pages

  Bashey, Sameer ^a   Krathen, Michael ^a   Abdulla, Farah ^b   Sundram, Uma ^a   Kim, Youn H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BEXAROTENE; CD3 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; DOXYCYCLINE; HEMOGLOBIN; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; ROMIDEPSIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALOPECIA; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CASE REPORT; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FATIGUE; FEMALE; FEVER; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOPHAGOCYTIC SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOPENIA; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SKIN BIOPSY; SUBCUTANEOUS FAT; SUBCUTANEOUS NODULE; SUBCUTANEOUS T CELL LYMPHOMA; THROMBOCYTOPENIA; WEIGHT REDUCTION;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; DEPSIPEPTIDES; FEMALE; HUMANS; LYMPHOMA, T-CELL; PANNICULITIS;

EID: 84865220518     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.41.5976     Document Type: Article

References (38)

1. Willemze R, Jansen PM, Cerroni L, et al: Subcutaneous panniculitis-like T-cell lymphoma: Definition, classification, and prognostic factors: An EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 111:838-845, 2008
2. Jaffé ES, Gaulard P, Ralfkiaer, et al: Subcutaneous panniculitis-like T-cell lymphoma, in Swerdlow SH, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2008, pp 294-295
3. Cerroni L, Gatter K, Kerl H: Skin Lymphoma. Oxford, United Kingdom, Wiley-Blackwell, 2009, pp 87-96
4. Koh MJ, Sadarangani SP, Chan YC, et al: Aggressive subcutaneous panniculitis-like T-cell lymphoma with hemophagocytosis in two children (subcutaneous panniculitis-like T-cell lymphoma). J Am Acad Dermatol 61:875-881, 2009
5. Kumar S, Krenacs L, Medeiros J, et al: Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Path 29:397-403, 1998 (Pubitemid 28231906)
6. Hoque SR, Child FJ, Whittaker SJ, et al: Subcutaneous panniculitis-like T-cell lymphoma: A clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol 148:516-525, 2003 (Pubitemid 36461331)
7. Wang CY, Su WP, Kurtin PJ: Subcutaneous panniculitis T-cell lymphoma. Int J Dermatol 35:1-8, 1996
8. El-Shabrawi-Caelen L, Cerroni L, Kerl H: The clinicopathologic spectrum of cytotoxic lymphomas of the skin. Semin Cutan Med Surg 19:118-123, 2000 (Pubitemid 30448106)
9. Cerroni L, Kerl H: Diagnostic immunohistology: Cutaneous lymphomas and pseudolymphomas. Semin Cutan Med Surg 18:64-70, 1999 (Pubitemid 29165100)
10. Santucci M, Pimpinelli N, Massi D, et al: Cytotoxic/natural killer cell cutaneous lymphomas: Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 97:610-627, 2003 (Pubitemid 36125838)
11. Massone C, Chott A, Metze D, et al: Subcutaneous, blastic natural killer (NK), NK/T-cell and other cytotoxic lymphomas of the skin: A morphologic, immunophenotypic and molecular study of 50 patients. Am J Surg Pathol 28:719-735, 2004 (Pubitemid 38685886)
12. Salhany KE, Macon WR, Choi JK, et al: Subcutaneous panniculitis-like T-cell lymphoma: Clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 22:881-893, 1998 (Pubitemid 28328234)
13. Toro JR, Beaty M, Sorbara L, et al: Gamma delta T-cell lymphoma of the skin: A clinical, microscopic, and molecular study. Arch Dermatol 136:1024-1032, 2000 (Pubitemid 30629130)
14. Gonzalez CL, Medeiros LJ, Braziel RM, et al: T-cell lymphoma involving the subcutaneous tissue: A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 15:17-27, 1991
15. Henter JI, Horne A, Aricó M, et al: HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48: 124-131, 2007
16. Blom A, Beylot-Barrie M, D'Incan M, et al: Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma. J Am Acad Dermatol 65:404-410, 2011
17. Go RS, Wester SM: Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: A systematic analysis of 156 patients reported in the literature. Cancer 101:1404-1413, 2004 (Pubitemid 39180396)
18. Papenfuss JS, Aoun P, Bierman PJ, et al: Subcutaneous panniculitis-like T-cell lymphoma: Presentation of 2 cases and observations. Clin Lymphoma 3:175-180, 2002 (Pubitemid 36113690)
19. Levy Y, George J, Abraham A, et al: Subcutaneous T-cell lymphoma in a patient with rheumatoid arthritis not treated with cytotoxic agents. Clin Rheumatol 16:606-608, 1997 (Pubitemid 28341466)
20. Mehta N, Wayne A, Kim YH, et al: Bexarotene is active against subcutaneous panniculitis T-cell lymphoma in adults and pediatric populations. Clin Lymphoma Myeloma Leuk (in press)
21. Willemze R, Jaffé ES, Burg G, et al: WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768-3785, 2005
22. von den Driesch P, Staib G, Simon M Jr, et al: Subcutaneous T-cell lymphoma. J Am Acad Dermatol 36:285-289, 1997 (Pubitemid 27078888)
23. Mukai HY, Okoshi Y, Shimizu S, et al: Successful treatment of a patient with subcutaneous panniculitis-like T-cell lymphoma with high-dose chemotherapy and total body irradiation. Eur J Haematol 70:413-416, 2003 (Pubitemid 36713939)
24. Perniciaro C, Zalla MJ, White JW Jr, et al: Subcutaneous T-cell lymphoma: Report of two additional cases and further observations. Arch Dermatol 129: 1171-1176, 1993 (Pubitemid 23272099)
25. Koizumi K, Sawada K, Nishio M, et al: Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitis. Bone Marrow Transplant 20:171-173, 1997 (Pubitemid 27356735)
26. Reimer P, Rüdiger T, Müller J, et al: Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation. Ann Hematol 82:305-309, 2003
27. Rojnuckarin P, Nakorn TN, Assanasen T, et al: Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma. Leuk Lymphoma 48:560-563, 2007 (Pubitemid 46487766)
28. Briki H, Bouaziz JD, Molinier-Frenkel V, et al: Subcutaneous panniculitis-like T-cell lymphoma αβ: complete sustained remission with corticosteroids and methotrexate. Br J Dermatol 163:1136-1138, 2010
29. Chim CS, Loong F, Ng WK, et al: Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma. Am J Clin Dermatol 9:396-398, 2008
30. Ueda H, Nakajima H, Hori Y, et al: FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968: I-Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J Antibiot 47:301-310, 1994 (Pubitemid 24106520)
31. Peart MJ, Smyth GK, van Laar RK, et al: Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc Natl Acad Sci U S A 102:3697-3702, 2005 (Pubitemid 40354674)
32. Johnstone RW, Licht JD: Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target? Cancer Cell 4:13-18, 2003 (Pubitemid 36904157)
33. Bolden JE, Peart MJ, Johnstone RW: Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5:769-784, 2006 (Pubitemid 44348499)
34. Cress WD, Seto E: Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 184:1-16, 2000 (Pubitemid 30349623)
35. Vigushin DM, Coombes RC: Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs 13:1-13, 2002 (Pubitemid 34169522)
36. Santini V, Gozzini A, Ferrari G: Histone deacetylase inhibitors: Molecular and biological activity as a premise to clinical application. Curr Drug Metab 8:383-393, 2007
37. Pierkarz RL, Frye R, Turner M, et al: Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol 27:5410-5417, 2009
38. Whittaker SJ, Demierre MF, Kim EJ, et al: Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma. J Clini Oncol 28:4485-4491, 2010